VSBLTY Groupe Technologies Corp. completed the second tranche of its non-brokered private placement, issuing 6.53 million units at C$0.105 each, raising approximately C$686,000. The units include common shares and warrants exercisable at C$0.18 for five years. Additionally, the company settled C$137,733 of debt by issuing 5.68 million units, including to insiders, under related party transaction exemptions. VSBLTY also converted convertible debentures into shares and warrants, granted restricted share units and stock options to directors and employees, and confirmed its upcoming Annual General Meeting will be held as planned. The proceeds will support general working capital needs as the company advances its AI and sensor fusion technology platform.
Nuvei announced it will acquire Payoneer in an all-cash deal valued at $2.75 billion, offering Payoneer shareholders $7.40 per share. The merger aims to create a global commerce platform supporting businesses in over 190 countries, enhancing payment ...
Eli Lilly announced that its Phase 3 BRUIN CLL-322 trial showed adding Jaypirca (pirtobrutinib) to venetoclax and rituximab significantly improved progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or...
The osteoarthritis market is projected to grow at a moderate CAGR of 3% from 2026 to 2036, driven by an aging population and increasing disease prevalence. Emerging therapies like LEVI-04, ZILOSUL, TissueGene-C, and others are expected to enter the m...
A class action lawsuit has been filed against Nano-X Imaging Ltd. and some of its officers, accusing them of making false and misleading statements about the company's operations and prospects between March 31, 2025, and April 17, 2026. The lawsuit c...
Rhythm Pharmaceuticals reported encouraging six-month Phase 2 trial results for setmelanotide in patients with Prader-Willi syndrome, showing improvements in BMI, body composition, hyperphagia, and behavior. The study involved 18 patients aged 6 to 2...
